Special Initiatives

Personalized Medicine

Personalized Medicine Initiative

 
Since 2002, Phoenix set out to establish itself in the rapidly changing, highly competitive field of bioscience.

  • A new, independent Translational Genomics Research Institute (TGen) took root through a public-private partnership.

  • Arizona State University launched the ambitious Biodesign Institute to solve some of the world’s most urgent health and environmental problems.


    In January 2006, Piper Trust announced a commitment to invest $50 million in the newly emerging field of personalized medicine. This investment had the potential for catalytic change in medical research by strengthening local institutions, creating a network of collaborative research endeavors and attracting high profile researchers.

    A breakthrough occurred in October 2007 when Dr. Lee Hartwell, Nobel laureate and director of Fred Hutchinson Cancer Research Center, Seattle, became interested in the potential Phoenix had to support a major personalized medicine collaboration with TGen and ASU Biodesign to create the Partnership for Personalized Medicine.

    Since then, a major lung cancer initiative with the Duchy of Luxembourg has come on line and Dr. Hartwell and Dr. Josh LaBaer, a renowned proteomics researcher from Harvard University joined the Biodesign Institute.

    FOR MORE INFORMATION ABOUT BIOSCIENCE IN ARIZONA:       

  • .